ALLEN R GRIGGS

Allopathic & Osteopathic Physicians|Internal Medicine EMERSON, NJ NPI 1912935669

General Payments — all program years on this page

$1,890.19

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 117
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $291.14 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $291.1415

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Medtronic, Inc. $69.832
Amgen Inc. $51.863
GlaxoSmithKline, LLC. $48.323
ABBVIE INC. $46.653
Boehringer Ingelheim Pharmaceuticals, Inc. $32.452
DePuy Synthes Sales Inc. $22.531
Cleerly, Inc. $19.501

By program year

Program yearAmountRecords
2018 $718.5748
2019 $390.2229
2020 $26.102
2022 $307.8513
2023 $156.3110
2024 $291.1415

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077871560 DePuy Synthes Sales Inc. $22.53 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103840220 ABBVIE INC. $17.23 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103840222 ABBVIE INC. $13.61 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103840224 ABBVIE INC. $15.81 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589738 Amgen Inc. $17.60 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589740 Amgen Inc. $16.93 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589742 Amgen Inc. $17.33 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115912758 GlaxoSmithKline, LLC. $16.93 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116240560 GlaxoSmithKline, LLC. $16.39 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116404235 GlaxoSmithKline, LLC. $15.00 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118233828 Boehringer Ingelheim Pharmaceuticals, Inc. $15.70 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118233830 Boehringer Ingelheim Pharmaceuticals, Inc. $16.75 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119546257 Medtronic, Inc. $37.73 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119546259 Medtronic, Inc. $32.10 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144711952 Cleerly, Inc. $19.50 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.